André Schaeftlein

Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients

Iris K. Minichmayr, André Schaeftlein, Joseph L. Kuti et al. · Clinical Pharmacokinetics · 2016 · 63 citations

Clinical Determinants, Critically Ill Patients, Critical Care Medicine +9

Pharmacokinetics of Intravenous and Oral Linezolid in Adults with Cystic Fibrosis

Rebecca A. Keel, André Schaeftlein, Charlotte Kloft et al. · Antimicrobial Agents and Chemotherapy · 2011 · 62 citations

Contemporary Mrsa Isolates, Antimicrobial Susceptibility, Pharmacokinetic Modeling +14

A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Model of Dabigatran Etexilate, Dabigatran and Dabigatran Glucuronide in Healthy Adults and Renally Impaired Patients

Daniel Moj, Hugo Maas, André Schaeftlein et al. · Clinical Pharmacokinetics · 2019 · 23 citations

Pharmacokinetic Modeling, Dabigatran Etexilate, Physiologically-based Pharmacokinetic Modeling +10

Population pharmacokinetics and pharmacodynamic evaluation of intravenous and enteral moxifloxacin in surgical intensive care unit patients

Martin G. Kees, André Schaeftlein, Helene A. Haeberle et al. · Journal of Antimicrobial Chemotherapy · 2013 · 15 citations · Full text

Which Analysis Approach Is Adequate to Leverage Clinical Microdialysis Data? A Quantitative Comparison to Investigate Exposure and Response Exemplified by Levofloxacin

David Busse, André Schaeftlein, Alexander Solms et al. · Pharmaceutical Research · 2021 · 10 citations · Full text